MoneyWorks4Me

FDC - Quaterly Results

08 Nov 2023 Evaluate
The company witnessed a 7.50% growth in the revenue at Rs. 4796.98 millions for the quarter ended September 2023 as compared to Rs. 4462.21 millions during the year-ago period.Good  Net Profit growth of 40.50% reported above the corresponding previous quarter figure of Rs. 512.76 millions to Rs. 720.41 millioins.Operating profit for the quarter ended September 2023 rose to 1060.95 millions as compared to 797.60 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4796.98 4462.21 7.50 10097.38 9392.29 7.51 17770.32 15189.65 16.99
Other Income 273.85 286.31 -4.35 571.69 480.30 19.03 539.12 787.34 -31.53
PBIDT 1060.95 797.60 33.02 2558.85 1791.78 42.81 3084.87 3255.80 -5.25
Interest 10.51 10.11 3.96 20.89 17.07 22.38 40.39 30.48 32.51
PBDT 1050.44 787.49 33.39 2537.96 1774.71 43.01 3044.48 3225.32 -5.61
Depreciation 98.13 99.38 -1.26 194.01 192.55 0.76 387.58 370.81 4.52
PBT 952.31 688.11 38.40 2343.95 1582.16 48.15 2656.90 2854.51 -6.92
TAX 231.90 175.35 32.25 538.03 339.21 58.61 647.25 658.15 -1.66
Deferred Tax 16.71 -7.65 -318.43 17.84 -86.79 -120.56 -42.75 -21.85 95.65
PAT 720.41 512.76 40.50 1805.92 1242.95 45.29 2009.65 2196.36 -8.50
Equity 162.81 165.91 -1.87 165.91 165.91 0.00 165.91 168.81 -1.72
PBIDTM(%) 22.12 17.87 23.73 25.34 19.08 32.84 17.36 21.43 -19.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..